Christopher Peetz, CHIEF EXECUTIVE OFFICER at Mirum Pharmaceuticals, Inc. (MIRM), sold 54,558 shares at $44.21 ($2.4M) on 2025-03-17, disclosed to the SEC on 2025-03-18.
Open-market sale of $2.4M MIRM by CHIEF EXECUTIVE OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.21 | 27,279 | $1.2M | 50.0% |
| 2 | $44.21 | 27,279 | $1.2M | 50.0% |
| Total | $44.21 avg | 54,558 | $2.4M | 100% |
| Filing → |
| MIRM | SELL | 2026-07-08 | $2.4M | — | Filing → |
| MIRM | SELL | 2026-06-02 | $2.9M | — | Filing → |
| MIRM | SELL | 2026-03-17 | $7.5M | — | Filing → |